Phibro Animal Health Corporation (PAHC) financial statements (2022 and earlier)

Company profile

Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR
TEANECK, NJ 07666
State of Incorp. DE
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q2
9/30/2021
Q1
6/30/2021
Q4
3/31/2021
Q3
12/31/2020
Q2
9/30/2020
Q1
6/30/2020
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:95,48597,17591,60193,10395,53491,96991,343
Cash and cash equivalents63,38541,17550,21249,10334,53430,96936,343
Short-term investments32,10056,00043,00044,00061,00061,00055,000
Other undisclosed cash, cash equivalents, and short-term investments  (1,611)    
Receivables142,495140,644146,852135,562126,026125,457126,522
Inventory, net of allowances, customer advances and progress billings230,784221,313216,312206,258213,331205,846196,659
Inventory230,784221,313216,312206,258213,331205,846196,659
Other current assets39,84639,49842,53336,79542,27641,01037,313
Other undisclosed current assets  1,611    
Total current assets:508,610498,630498,909471,718477,167464,282451,837
Noncurrent Assets
Property, plant and equipment154,584152,830154,706150,188150,337147,256148,109
Intangible assets, net (including goodwill)110,650112,804114,961117,113119,309121,471123,676
Goodwill52,67952,67952,67952,67952,67952,67952,679
Intangible assets, net (excluding goodwill)57,97160,12562,28264,43466,63068,79270,997
Other noncurrent assets75,11471,78072,74965,99856,83856,54560,478
Total noncurrent assets:340,348337,414342,416333,299326,484325,272332,263
TOTAL ASSETS:848,958836,044841,325805,017803,651789,554784,100
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities153,503141,336154,741145,454145,028140,640138,488
Accounts payable80,66366,80568,36262,80363,30662,49766,091
Accrued liabilities72,84074,53186,37982,65181,72278,14372,397
Debt13,12511,2509,37523,43721,87520,31218,750
Total current liabilities:166,628152,586164,116168,891166,903160,952157,238
Noncurrent Liabilities
Long-term debt and lease obligation, including:293,442295,264297,085204,223208,818213,412368,257
Long-term debt, excluding current maturities387,317394,014382,710356,786364,943378,100368,257
Other undisclosed long-term debt and lease obligation(93,875)(98,750)(85,625)(152,563)(156,125)(164,688) 
Liabilities, other than long-term debt55,71956,13961,67263,41958,48358,09070,401
Liability for uncertainty in income taxes  5,702    
Other liabilities55,71956,13955,97063,41958,48358,09070,401
Other undisclosed noncurrent liabilities93,87598,75079,923152,563156,125164,688 
Total noncurrent liabilities:443,036450,153438,680420,205423,426436,190438,658
Total liabilities:609,664602,739602,796589,096590,329597,142595,896
Stockholders' equity
Stockholders' equity attributable to parent, including:239,294233,305238,529215,921213,322192,412188,204
Additional paid in capital135,803135,803135,803136,654136,654136,090135,525
Accumulated other comprehensive loss(128,806)(122,191)(115,293)(126,492)(121,790)(134,190)(130,385)
Retained earnings232,293219,689218,015205,755198,454190,508183,060
Other undisclosed stockholders' equity attributable to parent4444444
Total stockholders' equity:239,294233,305238,529215,921213,322192,412188,204
TOTAL LIABILITIES AND EQUITY:848,958836,044841,325805,017803,651789,554784,100

Income statement (P&L) ($ in thousands)

12/31/2021
Q2
9/30/2021
Q1
6/30/2021
Q4
3/31/2021
Q3
12/31/2020
Q2
9/30/2020
Q1
6/30/2020
Q4
Revenues232,712214,665220,278211,729206,149195,194185,883
Cost of revenue
(Cost of Goods and Services Sold)
(162,040)(149,987)(150,450)(142,564)(137,884)(131,075)(125,319)
Gross profit:70,67264,67869,82869,16568,26564,11960,564
Operating expenses(48,378)(50,066)(50,670)(49,033)(48,375)(48,431)(42,445)
Operating income:22,29414,61219,15820,13219,89015,68818,119
Nonoperating income (expense)
(Foreign Currency Transaction Gain (Loss), before Tax)
4,189(2,128)890583(624)3,6311,069
Interest and debt expense(3,102)(3,065)(4,052)(3,081)(3,476)(3,109)(3,182)
Income from continuing operations before equity method investments, income taxes:23,3819,41915,99617,63415,79016,21016,006
Other undisclosed income from continuing operations before income taxes149176129148262299375
Income from continuing operations before income taxes:23,5309,59516,12517,78216,05216,50916,381
Income tax expense (benefit)(6,065)(3,061)996(5,621)(3,251)(4,207)(10,739)
Net income available to common stockholders, diluted:17,4656,53417,12112,16112,80112,3025,642

Comprehensive Income ($ in thousands)

12/31/2021
Q2
9/30/2021
Q1
6/30/2021
Q4
3/31/2021
Q3
12/31/2020
Q2
9/30/2020
Q1
6/30/2020
Q4
Net income:17,4656,53417,12112,16112,80112,3025,642
Other undisclosed comprehensive loss  (1,478)    
Comprehensive income:17,4656,53415,64312,16112,80112,3025,642
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(6,615)(6,898)12,677(4,702)12,400(3,805)(8,493)
Comprehensive income (loss), net of tax, attributable to parent:10,850(364)28,3207,45925,2018,497(2,851)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: